Showing all 3 results
GlyHealth-COVID is being developed to identify immunofrail individuals likely to suffer serious inflammatory episodes if they were to be infected with SARS-Cov-2 virus.
GlyHealth-IBD is the most advanced of our disease-specific GlyHealth variants. It is a prognostic and predictive biomarker of inflammatory bowel disease (IBD).
Glycan-based test that measures the fitness of your immune system and helps to learn about the nature of your inflammation from a small amount of blood.